A Study of LY900014 in Participants With Type 2 Diabetes Mellitus

NCT03305822 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY900014
DRUG: Insulin Lispro

Sponsor

Eli Lilly and Company